HIV chemotherapy (Q34223088)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	HIV chemotherapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

HIV chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

0 references

author name string

Richman DD

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

410

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

6831

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

995-1001

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Viral dynamics of HIV: implications for drug development and therapeutic strategies

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Polygenic and multifactorial disease gene association in man: Lessons from AIDS.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Quantitative image analysis of HIV-1 infection in lymphoid tissue

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Predominance of Distinct Viral Genotypes in Brain and Lymph Node Compartments of HIV-1-Infected Individuals

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

HIV-1 V3 domain variation in brain and spleen of children with AIDS: tissue-specific evolution within host-determined quasispecies

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Distinct but related human immunodeficiency virus type 1 variant populations in genital secretions and blood

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4+ T Cells

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

HIV-protease inhibitors

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Antiretroviral drugs and the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

New targets for inhibitors of HIV-1 replication

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Protein design of an HIV-1 entry inhibitor

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Protease inhibitor-based therapy is associated with decreased HIV-related health care costs in men treated at a Veterans Administration hospital

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Cost effectiveness of combination HIV therapy: 3 years later

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine

1 reference

https://api.crossref.org/works/10.1038%2F35073673

21 January 2018

Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2F35073673

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2F35073673

7 January 2021

based on heuristic

inferred from DOI database lookup

Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1038%2F35073673

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1038%2F35073673

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in thymic function with age and during the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1038%2F35073673

7 January 2021

based on heuristic

inferred from DOI database lookup

Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1

1 reference

https://api.crossref.org/works/10.1038%2F35073673

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus retinitis in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2F35073673

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Fédération National des Centres de Lutte contre le SIDA

1 reference

https://api.crossref.org/works/10.1038%2F35073673

7 January 2021

based on heuristic

inferred from DOI database lookup

The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1038%2F35073673

7 January 2021

based on heuristic

inferred from DOI database lookup

Fat distribution and metabolic changes in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1038%2F35073673

7 January 2021

based on heuristic

inferred from DOI database lookup

Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase

1 reference

https://api.crossref.org/works/10.1038%2F35073673

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimating the national cost of treating people with HIV disease: patient, payer, and provider data

1 reference

https://api.crossref.org/works/10.1038%2F35073673

7 January 2021

based on heuristic

inferred from DOI database lookup

Costs of HIV medical care in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2F35073673

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of SIV rebound through structured treatment interruptions during early infection

1 reference

https://api.crossref.org/works/10.1038%2F35073673

7 January 2021

based on heuristic

inferred from DOI database lookup

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1038%2F35073673

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/35073673

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34223088&oldid=2196396113"